Dr. Kenneth Michael Downes, MD

Dr. Downes practices at Physician Surgery Center of Albuquerque in Albuquerque, New Mexico.

Dr. Downes' NPI, 1215226014, was assigned on April 1, 2011. Dr. Downes graduated from University of New Mexico School of Medicine in 2011. Dr. Downes holds New Mexico license MD2017-0187.

Dr. Downes' primary practice is Physician Surgery Center of Albuquerque, at 9551 Paseo Del Norte Ne Ste C, Albuquerque, NM 87122. The practice phone is (505) 639-4640.

Dr. Downes' primary practice is Physician Surgery Center of Albuquerque in Albuquerque, New Mexico. Dr. Downes is also affiliated with University of New Mexico Hospital. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Downes to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Downes practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Downes' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Downes' licenses on file in 3 states: New Mexico, California and Oregon.

CMS data shows 2,926 Medicare services from Dr. Downes across 17 procedure codes in 2024, for 1,061 Medicare patients. Medicare paid $254,293 for them.

CMS counts 1,061 Medicare patients who saw Dr. Downes in 2024. The largest group is 65 to 74, with 468 patients. 68% of them have high cholesterol, and 63% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Downes' median patient age at 73, with 61% women.

In 2024, Dr. Downes wrote 2,257 Medicare Part D claims for 670 patients. 50% of them were for generic drugs. CMS names the drug for 2,126 of them, across 25 drugs with 11 or more claims each, at $330,006 in total drug cost. In 2023, CMS named 1,674 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Downes for performance year 2024, reported as part of a group. Dr. Downes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Downes as offering telehealth. CMS counts 312 procedures of cataract surgery by Dr. Downes, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Downes, published from 2013 to 2015. The most frequent topics are Corneal Endothelial Cell Loss, Descemet Stripping Endothelial Keratoplasty and Tissue and Organ Harvesting. Dr. Downes has published most often in Cornea. Dr. Downes' most frequent co-authors are Rolake Oluwaseun Alabi, MD, PhD, Winston Douglas Chamberlain, MD, PhD and Christopher S. Sales, MD, MPH.

CMS Open Payments shows 241 general payments to Dr. Downes from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Alcon Laboratories Inc paid the most, $3,828.

Dr. Downes graduated from University of New Mexico School of Medicine in 2011.